{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:50:43Z","timestamp":1794959443900,"version":"4.9.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T00:00:00Z","timestamp":1717286400000},"content-version":"am","delay-in-days":671,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES005022"],"award-info":[{"award-number":["P30ES005022"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES031080"],"award-info":[{"award-number":["R01ES031080"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R15ES023148"],"award-info":[{"award-number":["R15ES023148"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R35ES031709"],"award-info":[{"award-number":["R35ES031709"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR003017"],"award-info":[{"award-number":["UL1TR003017"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hazardous Materials"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jhazmat.2022.129193","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T11:50:18Z","timestamp":1653047418000},"page":"129193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay"],"prefix":"10.1016","volume":"436","author":[{"given":"Xuelian","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Aleksunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/hep.27206","article-title":"Human drug\u2010induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump","volume":"60","author":"Aleo","year":"2014","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jhazmat.2022.129193_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1021\/tx500345j","article-title":"Defining molecular initiating events in the adverse outcome pathway framework for risk assessment","volume":"27","author":"Allen","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jhazmat.2022.129193_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2015.02.028","article-title":"Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum","volume":"591","author":"Andreazza","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"issue":"19","key":"10.1016\/j.jhazmat.2022.129193_bib6","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1016\/j.febslet.2007.03.046","article-title":"The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein","volume":"581","author":"Barouki","year":"2007","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.jhazmat.2022.129193_bib7","doi-asserted-by":"crossref","first-page":"A228","DOI":"10.1289\/ehp.121-a228","article-title":"Tox21 to date: steps toward modernizing human hazard characterization","volume":"121","author":"Betts","year":"2013","journal-title":"Environ. Health Perspect."},{"issue":"7","key":"10.1016\/j.jhazmat.2022.129193_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/15563650903140423","article-title":"Relevance of the aryl hydrocarbon receptor (AhR) for","volume":"47","author":"Bradshaw","year":"2009","journal-title":"Clin. Toxicol."},{"issue":"45","key":"10.1016\/j.jhazmat.2022.129193_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"1","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"issue":"4","key":"10.1016\/j.jhazmat.2022.129193_bib10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","article-title":"DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans","volume":"21","author":"Chen","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.jhazmat.2022.129193_bib11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00204-014-1276-9","article-title":"A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the \u2018rule-of-two\u2019 model","volume":"88","author":"Chen","year":"2014","journal-title":"Arch. Toxicol."},{"issue":"15\u201316","key":"10.1016\/j.jhazmat.2022.129193_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.drudis.2011.05.007","article-title":"FDA-approved drug labeling for the study of drug-induced liver injury","volume":"16","author":"Chen","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jhazmat.2022.129193_bib13","series-title":"Advances in Computational Toxicology","first-page":"259","article-title":"Predicting the risks of drug-induced liver injury in humans utilizing computational modeling","author":"Chen","year":"2019"},{"issue":"4","key":"10.1016\/j.jhazmat.2022.129193_bib14","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41374-020-00477-2","article-title":"Predictive modeling of estrogen receptor agonism, antagonism, and binding activities using machine- and deep-learning approaches","volume":"101","author":"Ciallella","year":"2021","journal-title":"Lab Invest."},{"issue":"15","key":"10.1016\/j.jhazmat.2022.129193_bib15","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acs.est.1c02656","article-title":"Revealing adverse outcome pathways from public high-throughput screening data to evaluate new toxicants by a knowledge-based deep neural network approach","volume":"55","author":"Ciallella","year":"2021","journal-title":"Environ. Sci. Technol."},{"issue":"4","key":"10.1016\/j.jhazmat.2022.129193_bib16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1021\/acs.chemrestox.8b00393","article-title":"Advancing computational toxicology in the big data era by artificial intelligence: data-driven and mechanism-driven modeling for chemical toxicity","volume":"32","author":"Ciallella","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jhazmat.2022.129193_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.yrtph.2018.04.018","article-title":"A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans","volume":"96","author":"Clark","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"9","key":"10.1016\/j.jhazmat.2022.129193_bib18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1021\/tx100131f","article-title":"Role of human glutathione S-transferases in the inactivation of reactive metabolites of clozapine","volume":"23","author":"Dragovic","year":"2010","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"10.1016\/j.jhazmat.2022.129193_bib19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/ci010132r","article-title":"Reoptimization of MDL keys for use in drug discovery","volume":"42","author":"Durant","year":"2002","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vascn.2013.12.003","article-title":"Progress in computational toxicology","volume":"69","author":"Ekins","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"12","key":"10.1016\/j.jhazmat.2022.129193_bib21","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1124\/dmd.110.035113","article-title":"A predictive ligand-based Bayesian model for human drug-induced liver injury","volume":"38","author":"Ekins","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jhazmat.2022.129193_bib22","series-title":"Guidance for Industry Drug-Induced Liver Injury: Premarketing Clinical Evaluation","author":"FDA","year":"2009"},{"key":"10.1016\/j.jhazmat.2022.129193_bib23","series-title":"Drug-Induced Liver Toxicity","first-page":"61","article-title":"Physicochemical properties and structural alerts","author":"Fisk","year":"2018"},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/tx900326k","article-title":"Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species","volume":"23","author":"Fourches","year":"2010","journal-title":"Chem. Res. Toxicol."},{"issue":"8","key":"10.1016\/j.jhazmat.2022.129193_bib25","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/acs.jcim.8b00297","article-title":"QSAR modeling of ToxCast assays relevant to the molecular initiating events of AOPs leading to hepatic steatosis","volume":"58","author":"Gadaleta","year":"2018","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.jhazmat.2022.129193_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/aivt.2017.0027","article-title":"An update on adverse outcome pathways leading to liver injury","volume":"3","author":"Gijbels","year":"2017","journal-title":"Appl. In Vitro Toxicol."},{"key":"10.1016\/j.jhazmat.2022.129193_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9420-5_1","article-title":"Mechanisms of drug-induced cholestasis","volume":"1981","author":"Gijbels","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.jhazmat.2022.129193_bib28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/tx1000865","article-title":"Developing structure-activity relationships for the prediction of hepatotoxicity","volume":"23","author":"Greene","year":"2010","journal-title":"Chem. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/tx600260a","article-title":"Applying mechanisms of chemical toxicity to predict drug safety","volume":"20","author":"Guengerich","year":"2007","journal-title":"Chem. Res. Toxicol."},{"issue":"8","key":"10.1016\/j.jhazmat.2022.129193_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tips.2016.05.006","article-title":"Recent structural insights into cytochrome P450 function","volume":"37","author":"Guengerich","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jhazmat.2022.129193_bib31","article-title":"Crizotinib and Sunitinib Induce Hepatotoxicity and Mitochondrial Apoptosis in L02 Cells via ROS and Nrf2 Signaling Pathway","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/toxsci\/kft223","article-title":"A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans","volume":"137","author":"Gustafsson","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00204-020-02669-7","article-title":"In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity","volume":"94","author":"Hengstler","year":"2020","journal-title":"Arch Toxicol."},{"key":"10.1016\/j.jhazmat.2022.129193_bib34","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1038\/ncomms10425","article-title":"Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization","volume":"7","author":"Huang","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.jhazmat.2022.129193_bib35","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1021\/acssuschemeng.0c09139","article-title":"Construction of a virtual opioid bioprofile: a data-driven QSAR modeling study to identify new analgesic opioids","volume":"9","author":"Jia","year":"2021","journal-title":"ACS Sustain. Chem. Eng."},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/ci700332k","article-title":"The trouble with QSAR (or how I learned to stop worrying and embrace fallacy)","volume":"48","author":"Johnson","year":"2008","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.jhazmat.2022.129193_bib37","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.20634","article-title":"Mechanisms of benzarone and benzbromarone-induced hepatic toxicity","volume":"41","author":"Kaufmann","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/kfs326","article-title":"Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans","volume":"132","author":"Khetani","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.jhazmat.2022.129193_bib39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1289\/ehp.1509763","article-title":"Mechanism profiling of hepatotoxicity caused by oxidative stress using antioxidant response element reporter gene assay models and big data","volume":"124","author":"Kim","year":"2016","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/qsar.19920110208","article-title":"MULTICASE 1. A hierarchical computer automated structure evaluation program","volume":"11","author":"Klopman","year":"1992","journal-title":"Quant. Struct.. Act Rel."},{"key":"10.1016\/j.jhazmat.2022.129193_bib41","doi-asserted-by":"crossref","first-page":"15932","DOI":"10.1038\/ncomms15932","article-title":"A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury","volume":"8","author":"Kohonen","year":"2017","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib42","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/acs.jcim.6b00518","article-title":"Predicting drug-induced cholestasis with the help of hepatic transporters-an in silico modeling approach","volume":"57","author":"Kotsampasakou","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.jhazmat.2022.129193_bib43","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41385-018-0019-2","article-title":"Aryl hydrocarbon receptor and intestinal immunity","volume":"11","author":"Lamas","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.jhazmat.2022.129193_bib44","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s00204-017-2045-3","article-title":"Adverse outcome pathways: opportunities, limitations and open questions","volume":"91","author":"Leist","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/acs.chemrestox.0c00374","article-title":"DeepDILI: deep learning-powered drug-induced liver injury prediction using model-level representation","volume":"34","author":"Li","year":"2021","journal-title":"Chem. Res. Toxicol."},{"issue":"9","key":"10.1016\/j.jhazmat.2022.129193_bib46","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10822-011-9468-3","article-title":"Mixed learning algorithms and features ensemble in hepatotoxicity prediction","volume":"25","author":"Liew","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jhazmat.2022.129193_bib47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13321-015-0053-y","article-title":"Data-driven identification of structural alerts for mitigating the risk of drug-induced human liver injuries","volume":"7","author":"Liu","year":"2015","journal-title":"J. Cheminform."},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jps.24230","article-title":"Evaluation of hypericin: effect of aggregation on targeting biodistribution","volume":"104","author":"Liu","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib49","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0022-3565(25)12207-6","article-title":"Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells","volume":"275","author":"Liu","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jhazmat.2022.129193_bib50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib51","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0022-3565(25)12206-4","article-title":"The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man","volume":"275","author":"Maggs","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.jhazmat.2022.129193_bib52","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1021\/tx7001228","article-title":"Sequential metabolism and bioactivation of the hepatotoxin benzbromarone: formation of glutathione adducts from a catechol intermediate","volume":"20","author":"McDonald","year":"2007","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/10408444.2015.1089471","article-title":"The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways","volume":"46","author":"Mellor","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib54","first-page":"347","article-title":"Phenols-Sources and Toxicity","volume":"16","author":"Micha\u0142owicz","year":"2007","journal-title":"Pol. J. Environ. Stud."},{"issue":"5","key":"10.1016\/j.jhazmat.2022.129193_bib55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/acs.chemrestox.5b00465","article-title":"Computational models for human and animal hepatotoxicity with a global application scope","volume":"29","author":"Mulliner","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jhazmat.2022.129193_bib56","series-title":"Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models","year":"2014"},{"key":"10.1016\/j.jhazmat.2022.129193_bib57","series-title":"Revised Guidance Document on Developing and Assessing Adverse Outcome Pathways","year":"2017"},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.jhazmat.2022.129193_bib59","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrd3408","article-title":"Managing the challenge of chemically reactive metabolites in drug development","volume":"10","author":"Park","year":"2011","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.vascn.2013.08.001","article-title":"A high content screening assay to predict human drug-induced liver injury during drug discovery","volume":"68","author":"Persson","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib61","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-3565(25)24566-9","article-title":"Metabolism and bioactivation of clozapine by human liver in vitro","volume":"272","author":"Pirmohamed","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jhazmat.2022.129193_bib62","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fphar.2016.00442","article-title":"A new structure-activity relationship (SAR) model for predicting drug-induced liver injury, based on statistical and expert-based structural alerts","volume":"7","author":"Pizzo","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jhazmat.2022.129193_bib63","series-title":"Drug-Induced Liver Toxicity","first-page":"21","article-title":"Detection, elimination, mitigation, and prediction of drug-induced liver injury in drug discovery","author":"Pognan","year":"2018"},{"issue":"5","key":"10.1016\/j.jhazmat.2022.129193_bib64","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jhazmat.2022.129193_bib65","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2020.03.009","article-title":"The uricosuric benzbromarone disturbs the mitochondrial redox homeostasis and activates the NRF2 signaling pathway in HepG2 cells","volume":"152","author":"Roos","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib66","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/bioinformatics\/btw640","article-title":"CIIPro: a new read-across portal to fill data gaps using public large-scale chemical and biological data","volume":"33","author":"Russo","year":"2017","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.jhazmat.2022.129193_bib67","doi-asserted-by":"crossref","first-page":"47001","DOI":"10.1289\/EHP3614","article-title":"Nonanimal models for acute toxicity evaluations: applying data-driven profiling and read-across","volume":"127","author":"Russo","year":"2019","journal-title":"Environ. Health Perspect."},{"issue":"10","key":"10.1016\/j.jhazmat.2022.129193_bib68","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1021\/acs.molpharmaceut.8b00546","article-title":"Comparing multiple machine learning algorithms and metrics for estrogen receptor binding prediction","volume":"15","author":"Russo","year":"2018","journal-title":"Mol. Pharm."},{"issue":"2\u20133","key":"10.1016\/j.jhazmat.2022.129193_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/15376510701857460","article-title":"MultiCASE expert systems and the REACH initiative","volume":"18","author":"Saiakhov","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"issue":"8","key":"10.1016\/j.jhazmat.2022.129193_bib70","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s00204-020-02767-6","article-title":"An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac","volume":"94","author":"Selvaraj","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib71","doi-asserted-by":"crossref","first-page":"a016709","DOI":"10.1101\/cshperspect.a016709","article-title":"Signaling by nuclear receptors","volume":"5","author":"Sever","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfv152","article-title":"Setting clinical exposure levels of concern for drug-induced liver injury (DILI) using mechanistic in vitro assays","volume":"147","author":"Shah","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"23\u201324","key":"10.1016\/j.jhazmat.2022.129193_bib73","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.drudis.2010.07.007","article-title":"The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform","volume":"15","author":"Shukla","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.jhazmat.2022.129193_bib74","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1289\/ehp.1104709","article-title":"Profiling environmental chemicals for activity in the antioxidant response element signaling pathway using a high throughput screening approach","volume":"120","author":"Shukla","year":"2012","journal-title":"Environ. Health Perspect."},{"issue":"9","key":"10.1016\/j.jhazmat.2022.129193_bib75","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/tx200168d","article-title":"Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States","volume":"24","author":"Stepan","year":"2011","journal-title":"Chem. Res. Toxicol."},{"issue":"3\u20134","key":"10.1016\/j.jhazmat.2022.129193_bib76","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drudis.2008.11.009","article-title":"The future of drug safety testing: expanding the view and narrowing the focus","volume":"14","author":"Stevens","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"6 Pt A","key":"10.1016\/j.jhazmat.2022.129193_bib77","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.bbadis.2018.03.009","article-title":"Benzbromarone aggravates hepatic steatosis in obese individuals","volume":"1864","author":"Sun","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib78","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cels.2017.06.003","article-title":"Unsupervised Extraction of Stable Expression Signatures from Public Compendia with an Ensemble of Neural Networks","volume":"5","author":"Tan","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.jhazmat.2022.129193_bib79","series-title":"Drug-Induced Liver Toxicity","first-page":"45","article-title":"Drug-Induced Liver Injury (DILI) classification and its application on human DILI risk prediction","author":"Thakkar","year":"2018"},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib80","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/toxsci\/kfs159","article-title":"A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening","volume":"128","author":"Thomas","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/tx00043a007","article-title":"Quinone methide formation from para isomers of methylphenol (cresol), ethylphenol, and isopropylphenol: relationship to toxicity","volume":"8","author":"Thompson","year":"1995","journal-title":"Chem. Res. Toxicol."},{"issue":"7","key":"10.1016\/j.jhazmat.2022.129193_bib82","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1289\/ehp.1205784","article-title":"Improving the human hazard characterization of chemicals: a Tox21 update","volume":"121","author":"Tice","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jhazmat.2022.129193_bib83","series-title":"Handbook of chemoinformatics Algorithms","first-page":"211","article-title":"Predictive quantitative structure-activity relationships modeling","author":"Tropsha","year":"2010"},{"issue":"5","key":"10.1016\/j.jhazmat.2022.129193_bib84","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0006-2952(95)00143-N","article-title":"Effect of the antiretroviral agent hypericin on rat liver mitochondria","volume":"50","author":"Utsumi","year":"1995","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.jhazmat.2022.129193_bib85","first-page":"655","article-title":"The impact of aggregation on the biodistribution of hypericin","volume":"28","author":"Van De Putte","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jhazmat.2022.129193_bib86","series-title":"The Nature of Statistical Learning Theory","article-title":"Methods of pattern recognition","author":"Vapnik","year":"2000"},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib87","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/toxsci\/kfu199","article-title":"Adverse outcome pathway (AOP) development I: strategies and principles","volume":"142","author":"Villeneuve","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jhazmat.2022.129193_bib88","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tox.2013.08.011","article-title":"The adverse outcome pathway concept: a pragmatic tool in toxicology","volume":"312","author":"Vinken","year":"2013","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/j.jhazmat.2022.129193_bib89","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1055\/s-0034-1384605","article-title":"Sex-dependent metabolic alterations of rat liver after 12-week exposition to haloperidol or clozapine","volume":"46","author":"von Wilmsdorff","year":"2014","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib90","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfy058","article-title":"Prediction of drug-induced hepatotoxicity using long-term stable primary hepatic 3D spheroid cultures in chemically defined conditions","volume":"163","author":"Vorrink","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jhazmat.2022.129193_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2015.04.004","article-title":"Role of cytochrome P450 monooxygenase in carcinogen and chemotherapeutic drug metabolism","volume":"74","author":"Wahlang","year":"2015","journal-title":"Adv. Pharmacol."},{"issue":"23","key":"10.1016\/j.jhazmat.2022.129193_bib92","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1016\/j.bmcl.2008.10.030","article-title":"Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation","volume":"18","author":"Walker","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"21","key":"10.1016\/j.jhazmat.2022.129193_bib93","doi-asserted-by":"crossref","first-page":"12760","DOI":"10.1021\/es503583j","article-title":"High throughput heuristics for prioritizing human exposure to environmental chemicals","volume":"48","author":"Wambaugh","year":"2014","journal-title":"Environ. Sci. Technol."},{"issue":"9","key":"10.1016\/j.jhazmat.2022.129193_bib94","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s11095-015-1687-1","article-title":"Developing enhanced blood-brain barrier permeability models: integrating external bio-assay data in QSAR modeling","volume":"32","author":"Wang","year":"2015","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.jhazmat.2022.129193_bib96","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00204-016-1918-1","article-title":"Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria","volume":"91","author":"Zhang","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.jhazmat.2022.129193_bib97","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/toxsci\/kfaa005","article-title":"Mechanism-driven read-across of chemical hepatotoxicants based on chemical structures and biological data","volume":"174","author":"Zhao","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.jhazmat.2022.129193_bib98","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/ci980033m","article-title":"Novel variable selection quantitative structure--property relationship approach based on the k-nearest-neighbor principle","volume":"40","author":"Zheng","year":"2000","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.jhazmat.2022.129193_bib99","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-pharmtox-010919-023324","article-title":"Big data and artificial intelligence modeling for drug discovery","volume":"60","author":"Zhu","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.jhazmat.2022.129193_bib100","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1021\/tx500145h","article-title":"Big data in chemical toxicity research: the use of high-throughput screening assays to identify potential toxicants","volume":"27","author":"Zhu","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jhazmat.2022.129193_bib101","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2014.04.010","article-title":"Chronic administration of fluoxetine or clozapine induces oxidative stress in rat liver: a histopathological study","volume":"59","author":"Zlatkovic","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.jhazmat.2022.129193_bib102","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1021\/tx800252e","article-title":"Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity","volume":"21","author":"Zvinavashe","year":"2008","journal-title":"Chem. Res. Toxicol."}],"container-title":["Journal of Hazardous Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304389422009839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304389422009839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T19:02:10Z","timestamp":1759604530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304389422009839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":102,"alternative-id":["S0304389422009839"],"URL":"https:\/\/doi.org\/10.1016\/j.jhazmat.2022.129193","relation":{},"ISSN":["0304-3894"],"issn-type":[{"value":"0304-3894","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay","name":"articletitle","label":"Article Title"},{"value":"Journal of Hazardous Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhazmat.2022.129193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129193"}}